Floatz logo

Glycerol Phenylbutyrate

Urea Cycle Disorders

AmgenSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Urea Cycle Disorders cohort.

Asset / SponsorPhaseRating
Rifaquizinone
TenNor Therapeutics (Suzhou) Limited
Phase 1/2CCC
Hepastem
Cellaion SA
Phase 1/2CCC

Same molecule, other indications

Glycerol Phenylbutyrate is also rated in:

hepatic encephalopathyDormant
B
Indicative ·
61 / 100
View asset →
cirrhosis of liverDormant
CCC
Indicative ·
54 / 100
View asset →
cystic fibrosisDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →